DENTSPLY SIRONA Stock Forecast, Price & News

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

Is DENTSPLY SIRONA a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA or view top-rated stocks.

What stocks does MarketBeat like better than DENTSPLY SIRONA?

Wall Street analysts have given DENTSPLY SIRONA a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DENTSPLY SIRONA wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a increase in short interest in August. As of August 13th, there was short interest totaling 3,040,000 shares, an increase of 25.1% from the July 29th total of 2,430,000 shares. Based on an average trading volume of 1,230,000 shares, the days-to-cover ratio is currently 2.5 days. Currently, 1.4% of the shares of the stock are sold short.
View DENTSPLY SIRONA's Short Interest.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for DENTSPLY SIRONA.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) posted its earnings results on Thursday, August, 5th. The medical instruments supplier reported $0.71 EPS for the quarter, topping the consensus estimate of $0.65 by $0.06. The medical instruments supplier had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.01 billion. DENTSPLY SIRONA had a net margin of 9.06% and a trailing twelve-month return on equity of 13.22%. The company's quarterly revenue was up 117.3% on a year-over-year basis. During the same quarter last year, the firm earned ($0.18) EPS.
View DENTSPLY SIRONA's earnings history.

How has DENTSPLY SIRONA's stock been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, XRAY stock has increased by 41.0% and is now trading at $60.01.
View which stocks have been most impacted by COVID-19.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Wednesday, August 4th. Investors of record on Friday, September 24th will be given a dividend of $0.11 per share on Friday, October 8th. This represents a $0.44 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend is Thursday, September 23rd.
View DENTSPLY SIRONA's dividend history.

Is DENTSPLY SIRONA a good dividend stock?

DENTSPLY SIRONA pays an annual dividend of $0.44 per share and currently has a dividend yield of 0.74%. DENTSPLY SIRONA does not yet have a strong track record of dividend growth. The dividend payout ratio of DENTSPLY SIRONA is 24.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 13.71% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share guidance of $2.900-$2.900 for the period, compared to the Thomson Reuters consensus estimate of $2.870. The company issued revenue guidance of $4.10 billion-$4.30 billion, compared to the consensus revenue estimate of $4.25 billion.

What price target have analysts set for XRAY?

8 brokerages have issued 1 year target prices for DENTSPLY SIRONA's shares. Their forecasts range from $47.00 to $79.00. On average, they expect DENTSPLY SIRONA's share price to reach $64.57 in the next year. This suggests a possible upside of 7.6% from the stock's current price.
View analysts' price targets for DENTSPLY SIRONA or view top-rated stocks among Wall Street analysts.

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:

• Don M. Casey, Chief Executive Officer & Director
• Jorge M. Gomez, Chief Financial Officer & Executive Vice President
• Cord F. Stähler, Chief Technology Officer & Senior Vice President
• Keith J. Ebling, Secretary, Executive VP & General Counsel
• Markus Boehringer, Senior Vice President

What is Don Casey's approval rating as DENTSPLY SIRONA's CEO?

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

Who are some of DENTSPLY SIRONA's key competitors?

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), STAAR Surgical (STAA), Quidel (QDEL), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of XRAY's competitors.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), The Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.83%), Price T Rowe Associates Inc. MD (8.39%), BlackRock Inc. (7.27%), Artisan Partners Limited Partnership (5.19%), State Street Corp (4.42%) and Atlanta Capital Management Co. L L C (3.47%). Company insiders that own DENTSPLY SIRONA stock include Eric Brandt, Gregory T Lucier, Michael C Alfano, Walter Petersohn, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA.

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, BlackRock Inc., Nuance Investments LLC, Atlanta Capital Management Co. L L C, New York State Common Retirement Fund, American Century Companies Inc., SG Americas Securities LLC, and Susquehanna Fundamental Investments LLC. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Walter Petersohn, and Willie A Deese.
View insider buying and selling activity for DENTSPLY SIRONA or view top insider-selling stocks.

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was acquired by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Balyasny Asset Management LLC, Marshall Wace North America L.P., PNC Financial Services Group Inc., Jupiter Asset Management Ltd., Royal Bank of Canada, Panagora Asset Management Inc., and Point72 Asset Management L.P..
View insider buying and selling activity for DENTSPLY SIRONA or or view top insider-buying stocks.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $60.01.

How much money does DENTSPLY SIRONA make?

DENTSPLY SIRONA has a market capitalization of $13.12 billion and generates $3.34 billion in revenue each year. The medical instruments supplier earns $-83,000,000.00 in net income (profit) each year or $1.79 on an earnings per share basis.

How many employees does DENTSPLY SIRONA have?

DENTSPLY SIRONA employs 15,000 workers across the globe.

When was DENTSPLY SIRONA founded?

DENTSPLY SIRONA was founded in 2016.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

Where are DENTSPLY SIRONA's headquarters?

DENTSPLY SIRONA is headquartered at 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at (844) 848-0137 or via email at [email protected].